CN102627620B - 一类苯并呋喃衍生物及其医药应用 - Google Patents
一类苯并呋喃衍生物及其医药应用 Download PDFInfo
- Publication number
- CN102627620B CN102627620B CN201210104623.4A CN201210104623A CN102627620B CN 102627620 B CN102627620 B CN 102627620B CN 201210104623 A CN201210104623 A CN 201210104623A CN 102627620 B CN102627620 B CN 102627620B
- Authority
- CN
- China
- Prior art keywords
- compound
- arh
- acceptable salt
- pharmacy acceptable
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
化合物 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | Olaparib |
活性强度 | ++ | +++ | ++ | +++ | ++ | ++ | ++ | + | + | +++ |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210104623.4A CN102627620B (zh) | 2012-04-10 | 2012-04-10 | 一类苯并呋喃衍生物及其医药应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210104623.4A CN102627620B (zh) | 2012-04-10 | 2012-04-10 | 一类苯并呋喃衍生物及其医药应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102627620A CN102627620A (zh) | 2012-08-08 |
CN102627620B true CN102627620B (zh) | 2015-12-16 |
Family
ID=46586042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210104623.4A Active CN102627620B (zh) | 2012-04-10 | 2012-04-10 | 一类苯并呋喃衍生物及其医药应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102627620B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103242273B (zh) * | 2012-02-09 | 2015-06-03 | 中国科学院上海药物研究所 | 2-芳基苯并呋喃-7-甲酰胺类化合物、其制备方法及用途 |
WO2017083488A1 (en) * | 2015-11-11 | 2017-05-18 | Warner Babcock Institute for Green Chemistry | Benzofuran derivatives for the treatment of cns and other disorders |
CN109134409B (zh) * | 2017-06-14 | 2023-09-29 | 中国科学院上海药物研究所 | 盐酸美呋哌瑞多晶型物及其制备方法与应用 |
CN109810100B (zh) * | 2017-11-21 | 2022-03-11 | 中国药科大学 | 含有苯并呋喃的parp-1和pi3k双靶点抑制剂 |
CN111320596A (zh) * | 2018-12-14 | 2020-06-23 | 甫康(上海)健康科技有限责任公司 | 盐酸美呋哌瑞多晶型物及其制备方法 |
WO2021136523A1 (zh) * | 2019-12-31 | 2021-07-08 | 甫康(上海)健康科技有限责任公司 | 一种用于***的药物组合及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000029384A1 (de) * | 1998-11-17 | 2000-05-25 | Basf Aktiengesellschaft | 2-phenylbenzimidazole und 2-phenylindole, deren herstellung und anwendung |
US7087637B2 (en) * | 2000-05-11 | 2006-08-08 | Basf Ag | Substituted indoles which are PARP inhibitors |
CN101641014A (zh) * | 2006-12-28 | 2010-02-03 | 艾博特公司 | 聚(adp-核糖)聚合酶抑制剂 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103242273B (zh) * | 2012-02-09 | 2015-06-03 | 中国科学院上海药物研究所 | 2-芳基苯并呋喃-7-甲酰胺类化合物、其制备方法及用途 |
-
2012
- 2012-04-10 CN CN201210104623.4A patent/CN102627620B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000029384A1 (de) * | 1998-11-17 | 2000-05-25 | Basf Aktiengesellschaft | 2-phenylbenzimidazole und 2-phenylindole, deren herstellung und anwendung |
US7087637B2 (en) * | 2000-05-11 | 2006-08-08 | Basf Ag | Substituted indoles which are PARP inhibitors |
CN101641014A (zh) * | 2006-12-28 | 2010-02-03 | 艾博特公司 | 聚(adp-核糖)聚合酶抑制剂 |
Also Published As
Publication number | Publication date |
---|---|
CN102627620A (zh) | 2012-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102627620B (zh) | 一类苯并呋喃衍生物及其医药应用 | |
US10793543B2 (en) | Selective C-KIT kinase inhibitor | |
Messaoudi et al. | Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide | |
CN102131801B (zh) | 1,2-二取代的杂环化合物 | |
US9273052B2 (en) | Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof | |
CN110325526B (zh) | 异喹啉和萘啶化合物 | |
CN103130723B (zh) | 一种多聚(adp-核糖)聚合酶抑制剂 | |
US8791116B2 (en) | Myosin light chain kinase inhibitor compounds, compositions and related methods of use | |
US20160046616A1 (en) | Nrf2 small molecule inhibitors for cancer therapy | |
CN104302635A (zh) | 5-[[4-[[吗啉-2-基]甲基氨基]-5-(三氟甲基)-2-吡啶基]氨基]吡嗪-2-腈及其治疗应用 | |
CN101233121A (zh) | Parp调节剂和癌症的治疗 | |
EP3048108B1 (en) | Thienopiperidine derivative and use thereof | |
Sestito et al. | Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme | |
CN102898377A (zh) | 一类新型酞嗪酮衍生物及其用途 | |
CN104140426B (zh) | 嘧啶并咪唑类化合物、其药物组合物及其制备方法和用途 | |
CN102898378A (zh) | 一类酞嗪酮衍生物及其应用 | |
CN101575333B (zh) | 一种喹唑啉衍生物及其医药用途 | |
US20230181580A1 (en) | Treatment of proliferative diseases of the cns | |
Ghorab et al. | Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitors | |
CN102627610B (zh) | 一类苯并咪唑类衍生物及其应用 | |
CN106146504B (zh) | 一种杂环并咪唑类化合物、其药物组合物及其制备方法和用途 | |
CN102264699A (zh) | 新的亚苄基-吲哚啉酮及它们的医疗和诊断用途 | |
CN107428757A (zh) | 杂环并咪唑类化合物、其药物组合物及其制备方法和用途 | |
CN102688234B (zh) | 吲哚酮衍生物作为rsk2抑制剂的合成与应用 | |
CN102617478B (zh) | 苯并咪唑、噁唑和噻唑衍生物的合成及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU SIMCERE PHARMACEUTICAL CO., LTD. Effective date: 20150625 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150625 Address after: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Applicant after: Jiangsu Simcere Pharmaceutical Research Company Limited Applicant after: Jiangsu Simcere Pharmaceutical Co., Ltd. Address before: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Applicant before: Jiangsu Simcere Pharmaceutical Research Company Limited |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160712 Address after: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Patentee after: Jiangsu Simcere Pharmaceutical Co., Ltd. Address before: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Patentee before: Jiangsu Simcere Pharmaceutical Research Company Limited Patentee before: Jiangsu Simcere Pharmaceutical Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201229 Address after: 570311 No. 2 Yaogu No. 3 Road, Xiuying District, Haikou City, Hainan Province Patentee after: Hainan Simcere Pharmaceutical Co.,Ltd. Address before: 210042 699 Xuanwu Road, Xuanwu District, Nanjing, Jiangsu -18 Patentee before: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd. |